Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial

Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee

Clin Mol Hepatol. 2024;30(4):807-823. Published online July 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0333

View: 1960 Download: 251 Web of Science: 1 Crossref: 2

Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis

Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2022;28(4):876-889. Published online September 19, 2022

DOI: https://doi.org/10.3350/cmh.2022.0231

View: 4763 Download: 137 Web of Science: 16 Crossref: 15

Case Report

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis

Seung Woon Park, Soon Ho Um, Han Ah Lee, Sang Hyun Kim, Yura Sim, Sun Young Yim, Yeon Seok Seo, Ho Sang Ryu

Clin Mol Hepatol. 2016;22(2):281-285. Published online June 1, 2016

DOI: https://doi.org/10.3350/cmh.2015.0040

View: 11931 Download: 177 Web of Science: 9 Crossref: 10

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with ⁹⁰Y microspheres

Sun Young Yim, Jin Dong Kim, Jin Yong Jung, Chang Ha Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Ho Sang Ryu, Yun Hwan Kim, Chong Suk Kim, Eun Shin

Clin Mol Hepatol. 2014;20(3):300-305. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.300

View: 8456 Download: 64 Web of Science: 9 Crossref: 11

Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma

Sang Jung Park, Chang Ha Kim, Jin Dong Kim, Soon Ho Um, Sun Young Yim, Min Ho Seo, Dae In Lee, Jun Hyuk Kang, Bora Keum, Yong Sik Kim

Clin Mol Hepatol. 2012;18(3):316-320. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.316

View: 8591 Download: 88 Crossref: 6

Original Article

Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test

Jong Jin Hyun, Yeon Seok Seo, Hyonggin An, Sun Young Yim, Min Ho Seo, Hye Sook Kim, Chang Ha Kim, Ji Hoon Kim, Bora Keum, Yong Sik Kim, Hyung Joon Yim, Hong Sik Lee, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu

Clin Mol Hepatol. 2012;18(1):56-62. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.56

View: 6952 Download: 55 Crossref: 9

Correspondence

Correspondence on Letter regarding “Comprehensive Analysis of Transcriptomic Biomarkers for Predicting Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma.”

Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Peng Wei, Ju-Seog Lee

Received September 23, 2024 Accepted September 28, 2024

DOI: https://doi.org/10.3350/cmh.2024.0828 [Accepted]

View: 351 Download: 21

Correspondence on Letter regarding “Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response.”

Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju-Seog Lee

Received September 23, 2024 Accepted October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0829 [Accepted]

View: 282 Download: 15

Correspondence on Letter regarding “Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors”

Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Ju-Seog Lee

Received September 23, 2024 Accepted October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0830 [Accepted]

View: 238 Download: 7

1 |

Viewed By 5098	MAFLD: How is it different from NAFLD?
Viewed By 5072	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4498	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4474	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4363	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 113	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search